Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Rhea-AI Summary

Krystal Biotech (NASDAQ: KRYS) has announced its participation in the Goldman Sachs 46th Annual Global Healthcare Conference, taking place in Miami on June 10, 2025. Chairman and CEO Krish S. Krishnan will engage in a fireside chat at 2:00 pm ET and conduct investor meetings throughout the day. The presentation will be accessible via webcast starting at 2:00 pm ET and will be available on the company's Investors section of their website.

News Market Reaction – KRYS

+4.43%

+4.43% Session move

In the trading session that priced this news, KRYS gained 4.43%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PITTSBURGH, June 03, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the Goldman Sachs 46^th Annual Global Healthcare Conference on June 10, 2025, in Miami. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 2:00 pm ET and host investor meetings throughout the day.

A webcast of the presentation will be available here beginning at 2:00 pm ET on Tuesday, June 10, 2025 and will be posted on the Investors section of the Company’s website.

About Krystal Biotech, Inc.

Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK^®, the Company’s first commercial product, is the first-ever redosable gene therapy and the first genetic medicine approved by the FDA and EMA for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and X (formerly Twitter).

CONTACT
Investors and Media:                                                                                        
Stéphane Paquette
Krystal Biotech
spaquette@krystalbio.com                                                                                   

FAQ

When is Krystal Biotech (KRYS) presenting at the Goldman Sachs Healthcare Conference 2025?

Krystal Biotech will present at the Goldman Sachs Healthcare Conference on June 10, 2025, at 2:00 pm ET in Miami.

Who will represent Krystal Biotech at the Goldman Sachs Healthcare Conference 2025?

Krish S. Krishnan, Chairman and Chief Executive Officer of Krystal Biotech, will represent the company at the conference.

How can investors watch Krystal Biotech's presentation at the Goldman Sachs conference?

The presentation will be available via webcast starting at 2:00 pm ET on June 10, 2025, and can be accessed through the Investors section of Krystal Biotech's website.

What type of presentation will Krystal Biotech give at the Goldman Sachs Healthcare Conference?

Krystal Biotech's CEO will participate in a fireside chat format presentation and host investor meetings throughout the day.